Cite
HARVARD Citation
Falkentoft, A. et al. (2018). MR‐proADM as a Prognostic Marker in Patients With ST‐Segment–Elevation Myocardial Infarction—DANAMI‐3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy. Journal of the American Heart Association. 7 (11), p. n/a. [Online].